This study evaluates the date of the first appropriate and/or inappropriate therapy in
patients implanted with a Guidant PRIZM or VITALITY defibrillator and is evaluating eventual
predictive risk factors for appropriate/inappropriate therapies as well as the influence of
the programmed parameters on these therapies.
Minimum age: 18 Years.
Maximum age: N/A.
Gender(s): Both.
CHU Pontchaillou, Rennes 35033, France
CHU Michalon, Grenoble 38043, France
CHU Angers, Angers 49033, France
CHU Tours, Tours 37044, France
CHU Montpellier, Montpellier 34295, France
CHU Nantes, Nantes 34295, France
CHU Rangueil, Toulouse 31403, France
CHU Rouen, Rouen 76031, France
CHU Clermont Ferrand, Clermont Ferrand 63003, France
GH La Timone, Marseille 13385, France
CH St. Joseph, Marseille 13008, France
CH Amiens, Amiens 80054, France
CH Besancon, Besancon 25030, France
CHG Chateauroux, Chateauroux 36019, France
CHU Hopital la Cavale Blanche, Brest 29609, France
CH La Roche sur Yon, La Roche sur Yon 85025, France
CHU D'Orleans, Orleans 45000, France
CHU Dupuytren, Limoges 87042, France
Hopital Antoine Beclere, Clamart 92140, France
Hopital Angouleme, Angouleme 16470, France
Hopital Nord, Marseille 13915, France
Hopital Neuro-cardiologique, Lyon 69394, France
Hopital Cote de Nacre, Caen 14033, France
CHRU Robert Debré, Reims 51092, France
CH Avignon, Avignon 84902, France
CMC Arnaud Tzanck, St. Laurent du Var 6700, France
CHG Aix en Provence, Aix en Provence 13616, France
Hôpital Princesse de Grâce, Monaco 98000, France
CHG Albi, Albi 81000, France
CHG Pau, Pau 64046, France
CHU Nice, Nice 6002, France
CHG Martigues, Martigues 13696, France
CHU Toulon, Toulon 83056, France